We examined the impact of ARMCX3 invalidation on the phospho-AKT/AKT, phospho-S6/S6, phospho-ERK/ERK and phospho-p38/p38 ratios in non-tumor tissue from DEN-treated LFD and HFD-fed mice. This evidence concerns the gene AKT1 and neoplasm.